ClinicalTrials.gg
RecruitingNCT07225023FEED-PTUpdated Apr 7, 2026

A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy for Dizziness

An interventional study of Embedded Emergency Department Physical Therapy and Usual Care in Dizziness, sponsored by Northwestern University. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-07.

Sponsored by Northwestern University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a multi-site feasibility trial of an embedded emergency department (ED) physical therapy care model for dizziness at two EDs in the Northwestern Medicine and University of Utah Health systems. The study intervention (embedded ED physical therapy) is a reconceptualization of the traditional outpatient physical therapy care model in which we place a physical therapist directly in the ED to initiate timely care for patients with dizziness; we previously evaluated this intervention in a single center randomized trial for low back pain. This multi-site feasibility trial will be comprised of 9 months of active intervention and 12 months of longitudinal data collection. The two sites will be parallel randomized 1:1 to receive either the embedded ED physical therapy condition (intervention, n=1) or usual care (control, n=1) via simple randomization. This trial focuses on feasibility outcomes - such as our ability to enroll participants, deliver the intervention with fidelity, and collect longitudinal patient-reported outcome data and electronic health record data.

Read the detailed description

After a 12-month milestone-driven planning and preparation phase, we will conduct a 21-month randomized feasibility clinical trial of the embedded ED physical therapy intervention at the Northwestern Medicine and University of Utah health systems, comprised of 9 months of active intervention and 12 months of longitudinal data collection. Two hospital EDs (Northwestern Memorial Hospital, University of Utah Hospital) will be randomized to receive either the embedded ED physical therapist intervention (treatment, n=1) or usual care (control, n=1). Following completion of the feasibility trial, the control site will receive the intervention as per standard waitlist procedures for randomized trials. A third hospital ED (Northwestern Lake Forest Hospital) will not participate in randomization or participant enrollment but will contribute baseline electronic health record data to assist in feasibility assessments for a future full-scale trial.

02

Conditions studied

  • Dizziness

Keywords

  • dizziness
  • Physical therapy
  • FEED-PT
  • Feasibility
  • Emergency Department
03

In context

Dizziness

226 studies on the registry are indexed under Dizziness; 56 are open to participants now.

This study's planned enrollment of 100 is above the median of 43 across 170 interventional studies indexed under Dizziness.

Browse Dizziness studies →

Lead sponsor

Northwestern University is the lead sponsor of 1,423 studies on the registry; 198 are open to participants now.

Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Emergency Department (ED) visit with primary diagnosis related to dizziness
  • ED visit occurring at an ED site participating in randomization (Northwestern Memorial Hospital, University of Utah Hospital)
  • ED visit check-in time during the hours of 8am-8pm
  • Age greater than or equal to 18 years; there is no age maximum
  • English or Spanish-speaking

Exclusion criteria

Exclusion Criteria:

  • Severe neurologic deficit concerning for ischemic or hemorrhagic stroke (i.e., that would necessitate activating a stroke code)
  • Currently in police custody
  • Unable to consent
  • Known pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Embedded Emergency Department Physical Therapy

    We place a physical therapist directly in the emergency department to initiate timely care for patients with dizziness rather than waiting on an outpatient referral to physical therapy, which can often take weeks to accomplish, if ever at all. The actual techniques and approaches used by the embedded ED physical therapist in this study (e.g., exercises, maneuvers, coaching) are standard-of-care and do not involve investigational interventions, devices, or drugs.

    Other: Embedded Emergency Department Physical Therapy

  • Other
    Usual Care

    Usual care treatment for dizziness presenting in the emergency department (ED). Usual care consists of any ED testing or treatment not involving an ED physical therapist in accordance with the treating physician's usual and customary practice. This could include diagnostic imaging, patient education and resources, and administration and/or prescribing of medications.

    Other: Usual Care

Interventions

  • OtherEmbedded Emergency Department Physical Therapy

    We place a physical therapist directly in the emergency department to initiate timely care for patients with dizziness rather than waiting on an outpatient referral to physical therapy, which can often take weeks to accomplish, if ever at all. The actual techniques and approaches used by the embedded ED physical therapist in this study (e.g., exercises, maneuvers, coaching) are standard-of-care and do not involve investigational interventions, devices, or drugs.

  • OtherUsual Care

    Standard-of-care treatment for dizziness presenting in the emergency department

06

What researchers measure

Primary outcomes

  1. Longitudinal participant surveys (effectiveness): missing data rate for the Dizziness Handicap Inventory

    Rate of missing data for assessments administered between baseline and 12 months. Variable type: binary / proportion.

    Time frame: 12 months

  2. Longitudinal participant surveys (effectiveness): screening-to-enrollment ratio

    Number of participants who enter screening compared to the number of participants who enroll in the study. Variable type: binary / proportion.

    Time frame: Baseline

  3. Longitudinal participant surveys (effectiveness): participant retention rate defined as completion of at least one follow-up survey.

    Ratio of participants enrolled to the number who complete at least one follow-up survey.

    Time frame: 12 months

  4. Electronic Health Record (EHR) extraction (implementation): adoption of Emergency Department (ED) physical therapy

    Adoption is defined as the number of potentially eligible dizziness ED visits have a documented order for a physical therapy evaluation. Cross-sectional at the level of site/Emergency Department during the trial. Variable type: Proportion.

    Time frame: Baseline

  5. Electronic Health Record (EHR) extraction (implementation): fidelity of Emergency Department (ED) physical therapy

    Fidelity is defined as the number of dizziness ED visits that have a structured research note documenting use of the protocol. Cross-sectional at the level of site/Emergency Department (ED) during the trial. Variable type: proportion.

    Time frame: Baseline

  6. Clinician surveys before and after implementation of the intervention (implementation): Normalisation Measure Development Questionnaire (NoMAD) questionnaire scores

    1-6 months prior to opening study to accrual and 1-6 months after the last participant enrolls at the site. Variable type: continuous.

    Time frame: 1-6 months prior to opening study to accrual and 1-6 months after the last participant enrolls at the site.

Secondary outcomes

  1. Longitudinal participant surveys (effectiveness): a sum of the missing data rate for the remaining Participant Reported Outcomes (PROs) combined.

    Missing data rate for each PRO will not be analyzed separately, but will be combined into one measurement as one outcome. PROs: nine-item Vestibular Activities Avoidance Instrument (VAAI), Global Rating of Change, Numeric Pain Rating Scale, additional healthcare utilization (e.g., physical therapy, ED, doctor's office), and a medication use survey.

    Time frame: 12 months

  2. Electronic Health Record (EHR) extraction (effectiveness): rate of subsequent health care encounters.

    Variable type: count, may be considered binary / proportion

    Time frame: 12 months

  3. Electronic Health Record (EHR) extraction (effectiveness): rate of prescribing sedating medications (including antihistamines and benzodiazepines)

    Variable type: count, may be considered binary / proportion

    Time frame: 12 months

  4. Electronic Health Record (EHR) extraction (effectiveness): rate of advanced diagnostic imaging

    Variable type: count, may be considered binary / proportion

    Time frame: 12 months

  5. Clinician surveys before and after implementation of the intervention (implementation): Acceptability of Intervention Measure (AIM)

    1-6 months prior to opening study to accrual and 1-6 months after the last participant enrolls at the site. Variable type: continuous. Minimum value is 4, Maximum value is 20. Higher scores = higher agreement with outcome.

    Time frame: 1-6 months prior to opening study to accrual and 1-6 months after the last participant enrolls at the site.

  6. Clinician surveys before and after implementation of the intervention (implementation): Intervention Appropriateness Measure (IAM)

    1-6 months prior to opening study to accrual and 1-6 months after the last participant enrolls at the site. Variable type: continuous. Minimum value is 4, Maximum value is 20. Higher scores = higher agreement with outcome.

    Time frame: 1-6 months prior to opening study to accrual and 1-6 months after the last participant enrolls at the site.

  7. Clinician surveys before and after implementation of the intervention (implementation): Feasibility of Intervention measure (FIM).

    1-6 months prior to opening study to accrual and 1-6 months after the last participant enrolls at the site. Variable type: continuous. Minimum value is 4, Maximum value is 20. Higher scores = higher agreement with outcome.

    Time frame: 1-6 months prior to opening study to accrual and 1-6 months after the last participant enrolls at the site.

Other outcomes

  1. Participant and clinician focus groups (implementation)

    These data will be collected and analyzed qualitatively.

    Time frame: 1-6 months before the first participant enrolls and 1-6 months after the study closes to follow-up.

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Scientific data and metadata will be archived into Northwestern University Libraries' institutional repository, Arch (https://arch.library.northwestern.edu/). Northwestern University faculty, students, and staff with a current NetID are allowed unlimited storage, file uploads, and hosting for their scientific work. Scientific data will be made available at the end of the award period or at the time of the corresponding publication, in the case of any publications that pre-date the award end date. Datasets resulting from this work will remain available in the repository in perpetuity or until deaccessioned at the discretion of the repository. Should the funding or organizational imperatives of the Northwestern University Libraries change, the Libraries will strive to provide at least one year notice, and devote resources to support the transition to another host institution and/or returning the data to the data producers.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Scientific data will be made available at the end of the award period or at the time of the corresponding publication, in the case of any publications that pre-date the award end date. Datasets resulting from this work will remain available in the repository in perpetuity or until deaccessioned at the discretion of the repository.

Access criteria: Access to scientific data and metadata will not be controlled after archiving. Arch is an open access repository that is focused on digital data archiving and unmediated public access to research results.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07225023
Collaborators
University of Utah, Northwestern Lake Forest Hospital, Northwestern Memorial Hospital, National Institute on Deafness and Other Communication Disorders (NIDCD)
Responsible party
Howard Kim (Associate Professor, Northwestern University) — Principal investigator
First posted
Nov 5, 2025
Start date
Apr 1, 2026
Primary completion
Jul 1, 2027 (estimated)
Completion
Apr 1, 2028 (estimated)
Last update
Apr 7, 2026

Study contacts

Howard Kim, MD, MS
Contact
howard.kim@northwestern.edu
312-926-0591

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion